SVB Leerink
Leerink Partners is a Boston-based, privately held healthcare-focused investment bank offering M&A advisory, capital markets, equity research, sales & trading, and corporate access services to biopharma, digital health, medtech, and healthcare services clients across the full lifecycle from growth-stage to large-cap.
- Company typePrivate
- Founded-
- HeadquartersBoston, United States
- Headcount—
- GTM typeB2B
- OfferingServices
What SVB Leerink does
Leerink Partners is a Boston-headquartered, privately held investment bank exclusively focused on the healthcare sector. The firm's platform spans four core service lines: Investment Banking (M&A advisory, capital markets, and strategic financial advisory), Equity Research, Sales & Trading, and Corporate Access, supported by insight offerings MEDACorp and the Center for Pharmacoeconomics. The firm serves clients across five healthcare subsectors: biopharma (the primary vertical), digital health and health technology, healthcare services, medical technology, and tools & diagnostics, with recent disclosed mandates ranging from a $125M follow-on to an $800M lead-left bookrunner offering.
The firm generates revenue primarily through transaction-based advisory and capital markets fees, with senior bankers leading client engagement from deal origination through closing. Go-to-market is enterprise-led direct sales, supplemented by a content-driven marketing approach built on research publications, podcasts, and the MEDACorp insights network. Distribution combines direct investment banking relationships with an institutional equities platform providing highly specialized connectivity to institutional investors. As of May 31, 2026, the firm has completed more than 1,500 transactions, raised over $220 billion in capital for healthcare clients, and executed 85+ M&A advisory mandates.
Leerink is a FINRA/SIPC member broker-dealer operating as an independent private firm with no disclosed parent company. The firm was previously known as SVB Leerink and maintains a global service footprint anchored by its Boston headquarters. There are no disclosed AI/ML capabilities, subsidiaries, or public ownership signals in the available source material.
SVB Leerink firmographics
Firmographics- Name
- SVB Leerink
- Legal name
- Leerink Partners
- Website
- https://svbsecurities.com
- Company type
- Private
- Operating status
- Operating
- Short description
- Leerink Partners is a Boston-based, privately held healthcare-focused investment bank offering M&A advisory, capital markets, equity research, sales & trading, and corporate access services to biopharma, digital health, medtech, and healthcare services clients across the full lifecycle from growth-stage to large-cap.
- Ownership category
- akta.pro rank
SVB Leerink industry classification
Industry- Product category
- Investment Banking
- NAICS
- Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Portfolio Management and Investment Advice (52394)
- SIC
- Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)
- akta.pro primary industry
- Industry-Specialist / Sector-Focused M&A Advisory (FSAEAGAJ)
- akta.pro secondary industries
- M&A Advisory (Buy-Side & Sell-Side) (BPAHAOAA), Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory) (BPAHAOAL)
Keywords
Where SVB Leerink is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SVB Leerink business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Investment Banking Advisory: Provides M&A advisory, capital markets, and strategic financial advisory services to healthcare companies. Revenue generated through advisory fees on transactions including follow-on offerings, term loan facilities, and exclusive financial advisory mandates.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise investment banking services for healthcare companies |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
SVB Leerink product offering
Product offeringCore offering
Leerink Partners operates as a healthcare-exclusive investment bank offering M&A advisory, capital markets execution (follow-on offerings, term loan facilities, IPO support), equity research with deep healthcare coverage, sales and trading services for institutional investors, and corporate access events. The firm serves healthcare companies across biopharma, digital health, healthcare services, medical technology, and tools & diagnostics, with senior bankers leading every step from deal origination to closing.
Product overview
Leerink Partners operates as a specialized healthcare investment bank offering a unified platform of financial services. The core offerings include Investment Banking (M&A advisory, capital markets), Institutional Equities (Equity Research, Sales & Trading, Corporate Access), and Insights (MEDACorp research platform, Center For Pharmacoeconomics). These services are interconnected: Investment Banking leverages Equity Research insights and Corporate Access for deal origination, while the Insights platform (MEDACorp and CPE) provides thought leadership that supports all client engagement activities.
Differentiator
Problem solved
Functional benefit
Products and services
- Investment Banking Provides financial advisory services including M&A advisory, capital markets solutions, and strategic guidance across healthcare sectors including biopharma, healthcare services, and medical technology. Serves clients ranging from growth-stage biotechs to large-cap pharmaceuticals.
- Equity Research
- Sales & Trading
- Corporate Access
- Capital Markets
- MEDACorp
- Center For Pharmacoeconomics (CPE)
Quantifiable outcome
- 1500+ Transactions Completed as of May 31, 2026
- +2 more outcomes
Companies that use SVB Leerink
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles2 records
SVB Leerink technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SVB Leerink partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
SVB Leerink competitors and assessment
Company assessmentDirect peers
- Guggenheim Partners: Runs a healthcare-focused investment banking and equity research platform targeting mid- and large-cap life sciences, biopharma, and MedTech issuers — a direct competitor to Leerink's healthcare-exclusive model.
- Centerview Partners: Elite independent advisory firm with a strong healthcare M&A franchise serving large-cap pharma, biotech, and healthcare services — directly comparable to Leerink on strategic deal advisory.
- Cantor Fitzgerald: Healthcare investment banking with strong biotech and specialty pharma advisory and equity research, positioning as a direct competitor in growth-stage healthcare capital markets.
- TD Cowen (Cowen and Company): Historically a healthcare-focused boutique with deep biotech and specialty pharma advisory, now part of TD Cowen. Competes directly with Leerink on biopharma capital markets and M&A mandates.
- Jefferies: Operates a dedicated healthcare investment banking franchise with strong biotech and MedTech advisory and equity research coverage, directly competing with Leerink for biopharma and diagnostics mandates.
- Piper Sandler: Healthcare-focused investment banking with strength in medtech and life sciences, directly competing with Leerink for growth-stage and mid-market healthcare mandates.
Emerging players
- Houlihan Lokey: Independent advisory firm building a healthcare M&A practice that increasingly competes with Leerink on healthcare services, MedTech, and life sciences transactions.
Broad incumbents
- JPMorgan: One of the largest healthcare investment banking franchises globally, with deep capital markets capabilities and full-product offerings that compete with Leerink on enterprise healthcare clients.
- Goldman Sachs: Bulge-bracket with a major healthcare investment banking and equity research franchise, competing for the largest healthcare M&A and capital markets mandates that Leerink also targets.
- Morgan Stanley: Bulge-bracket bank with a leading global healthcare investment banking franchise, offering full-service M&A advisory, capital markets, and equity research at scale — a larger but overlapping competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
SVB Leerink social profiles
Digital presenceSVB Leerink compliance and trust
Trust signalCompliance2 records
SVB Leerink financial estimates
Financial estimateRevenue estimate
Valuation estimate
SVB Leerink leadership team
Management profileNumber of profiles
Profiles3 records
SVB Leerink funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SVB Leerink M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SVB Leerink
What does SVB Leerink do?
Leerink Partners operates as a healthcare-exclusive investment bank offering M&A advisory, capital markets execution (follow-on offerings, term loan facilities, IPO support), equity research with deep healthcare coverage, sales and trading services for institutional investors, and corporate access events. The firm serves healthcare companies across biopharma, digital health, healthcare services, medical technology, and tools & diagnostics, with senior bankers leading every step from deal origination to closing.
Is SVB Leerink a public or private company?
SVB Leerink is a private company. It is classified as unknown and is currently operating.
When was SVB Leerink founded?
SVB Leerink was founded in -1.
Where is SVB Leerink based?
SVB Leerink is headquartered in Boston, United States, in the North America region.
How does SVB Leerink make money?
One revenue line is on record: investment Banking Advisory.
Who are SVB Leerink's main competitors?
Direct peers on record are Guggenheim Partners, Centerview Partners, Cantor Fitzgerald, TD Cowen (Cowen and Company), Jefferies and Piper Sandler. Houlihan Lokey is listed as an emerging player. Broad incumbents are JPMorgan, Goldman Sachs and Morgan Stanley.
Does SVB Leerink have an API?
No public API is recorded for SVB Leerink.
What industry is SVB Leerink in?
SVB Leerink's product category is Investment Banking. Its primary akta.pro industry code is FSAEAGAJ, Industry-Specialist / Sector-Focused M&A Advisory, with a secondary code of BPAHAOAA, M&A Advisory (Buy-Side & Sell-Side). Its NAICS code is 523 and its SIC code is 6211.